NovaBridge Biosciences (NBP)
Nasdaq: NBP · Pharmaceutical Preparations · Rockville, MD · filing with the SEC since 2019
Who runs NovaBridge Biosciences
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Gupta Srishti
Chief Executive Officer. First filing Jul 2026, latest Jul 8, 2026, 0 filings in all.
Officers reporting now
12
of 20 people with a filing in the last fifteen months
Directors reporting now
8
20 people on the record since 2026
Officerssales are open-market, Oct 19, 2025 to Oct 19, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Dennis Phillip Andrew | Chief Medical Officer | Mar 2026 | Sep 21, 2026 | 2 · $0.00 |
| Cao Sean Wuxiong | Chief Bus. Development Officer | Mar 2026 | Sep 11, 2026 | 2 · $100,000 |
| Xu Cong Claire | EVP, Clinical Development | Mar 2026 | Sep 1, 2026 | 3 · $0.00 |
| Hagler Mark Arnold | Chief Commercial Officer | Apr 2026 | Jul 10, 2026 | none |
| Lin Liwei Lorraine | General Counsel | Mar 2026 | Jul 10, 2026 | none |
| Gupta Srishti | Chief Executive Officer | Jul 2026 | Jul 8, 2026 | none |
| Chu Denny Hsueh Wen | EVP, Head of Strategic Partnership Exhibit List: Ex. 24.1 - Power of Attorney | Mar 2026 | Mar 24, 2026 | none |
| Fu Xi-Yong | Chief Executive Officer and Director Exhibit List: Ex. 24.1 - Power of Attorney | Mar 2026 | Mar 18, 2026 | none |
| Wu Joanna Xuqiong | Senior Vice President, Head of Operations, General Counsel (US) Exhibit List: Ex. 24.1 - Power of Attorney | Mar 2026 | Mar 18, 2026 | none |
| Lei Ming Kyler | Chief Financial Officer | Mar 2026 | Mar 18, 2026 | none |
| Zhang Xiaofan Neo | Chief Investment Officer | Mar 2026 | Mar 18, 2026 | none |
| Zhang Adeline Yi | Global Controller | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Oct 19, 2025 to Oct 19, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Woo Ian Ying | director | Mar 2026 | Oct 19, 2026 | none |
| Dewhurst Martin William | director | Sep 2026 | Sep 10, 2026 | none |
| Lenz Robert A. | director | Mar 2026 | Aug 25, 2026 | none |
| Fu Wei | director | Mar 2026 | Jun 30, 2026 | none |
| Yang Conor Chia-Hung | director | Apr 2026 | Apr 1, 2026 | none |
| Au Chun Kwok Alan | director | Mar 2026 | Mar 18, 2026 | none |
| Cunningham Emmett | director | Mar 2026 | Mar 18, 2026 | none |
| Liu Xin | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.